Rational design of a novel peripherally-restricted, orally active CB1 cannabinoid antagonist containing a 2,3-diarylpyrrole motif

Autor:	Hortala, Laurent1, Rinaldi-Carmona, Murielle1, Congy, Christian1, Boulu, Laurent1, Sadoun, Freddy2, Fabre, Gérard2, Finance, Olivier3, Barth, Francis1 francis.barth@sanofi-aventis.com
Zdroj:	Bioorganic & Medicinal Chemistry Letters. Aug2010, Vol. 20 Issue 15, p4573-4577. 5p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect